1. Home
  2. PLAB vs ZLAB Comparison

PLAB vs ZLAB Comparison

Compare PLAB & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$43.01

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$21.23

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
ZLAB
Founded
1969
2013
Country
United States
China
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
PLAB
ZLAB
Price
$43.01
$21.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$44.33
$49.60
AVG Volume (30 Days)
770.3K
668.9K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
9.09
38.46
EPS
0.74
N/A
Revenue
$535,276,000.00
$460,156,000.00
Revenue This Year
$6.70
$9.75
Revenue Next Year
$4.96
$26.03
P/E Ratio
$54.22
N/A
Revenue Growth
18.77
15.33
52 Week Low
$16.59
$15.96
52 Week High
$45.40
$44.34

Technical Indicators

Market Signals
Indicator
PLAB
ZLAB
Relative Strength Index (RSI) 62.19 68.58
Support Level $36.32 $17.11
Resistance Level $44.51 $27.23
Average True Range (ATR) 2.51 0.70
MACD 0.33 0.37
Stochastic Oscillator 89.99 96.08

Price Performance

Historical Comparison
PLAB
ZLAB

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: